Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Terlivaz
Terlipressin
Mallinckrodt Plc
Main Therapeutic Indication : Nephrology
Currency : USD
2023 Revenue in Millions : 16
2022 Revenue in Millions : 1
Growth (%) : 1,200
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF